On ECHEMI
Home > Drugs > Shanghai New Asiatic Medicine Industry Minhang Co., Ltd.

Shanghai New Asiatic Medicine Industry Minhang Co., Ltd.

  • Founded in:

    1989-07-06
  • Country:

    China China
  • Address:

    No. 1500, Kunyang Road, Minhang District, Shanghai
  • Tax NO.:

    91310112133354160Q
  • Registered Funds:

    57.5 million yuan
  • Email:

Related Drugs
Ciprofloxacin Hydrochloride Capsules
The main ingredient of this product is: Ciprofloxacin hydrochloride. Its chemical name is: 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7 (1-piperazinyl)-3-quinolinecarboxylic acid hydrochloride monohydrate. Molecular formula: C17H18FN3O3·HCl·H2O Molecular weight: 385.82
Name Description Content CAS NO. Registered Holders
Ciprofloxacin hydrochloride

This product has a broad-spectrum antibacterial effect, especially high antibacterial activity against aerobic Gram-negative bacilli. It has good antibacterial activity in vitro against the following bacteria: most bacteria of the Enterobacteriaceae family, including Citrobacter, cloacae, Enterobacter aerogenes, Escherichia coli, Klebsiella, Proteus, Salmonella, Shigella, Vibrio, Yersinia, etc. It often has antibacterial activity against multi-drug resistant bacteria. It has high antibacterial activity against penicillin-resistant Neisseria gonorrhoeae, enzyme-producing Haemophilus influenzae and Moraxella. It has antibacterial activity against most strains of Pseudomonas such as Pseudomonas aeruginosa. This product has antibacterial activity against methicillin-sensitive Staphylococcus, and only moderate antibacterial activity against Streptococcus pneumoniae, hemolytic Streptococcus and Enterococcus faecalis. It also has good effects on Chlamydia trachomatis, Mycoplasma, Legionella, and antibacterial activity against Mycobacterium tuberculosis and atypical mycobacteria. Poor antibacterial activity against anaerobic bacteria. Ciprofloxacin is a bactericide that acts on the A subunit of bacterial DNA gyrase, inhibiting DNA synthesis and replication, leading to bacterial death.

More

This product has a broad-spectrum antibacterial effect, especially high antibacterial activity against aerobic Gram-negative bacilli. It has good antibacterial activity in vitro against the following bacteria: most bacteria of the Enterobacteriaceae family, including Citrobacter, cloacae, Enterobacter aerogenes, Escherichia coli, Klebsiella, Proteus, Salmonella, Shigella, Vibrio, Yersinia, etc. It often has antibacterial activity against multi-drug resistant bacteria. It has high antibacterial activity against penicillin-resistant Neisseria gonorrhoeae, enzyme-producing Haemophilus influenzae and Moraxella. It has antibacterial activity against most strains of Pseudomonas such as Pseudomonas aeruginosa. This product has antibacterial activity against methicillin-sensitive Staphylococcus, and only moderate antibacterial activity against Streptococcus pneumoniae, hemolytic Streptococcus and Enterococcus faecalis. It also has good effects on Chlamydia trachomatis, Mycoplasma, Legionella, and antibacterial activity against Mycobacterium tuberculosis and atypical mycobacteria. Poor antibacterial activity against anaerobic bacteria. Ciprofloxacin is a bactericide that acts on the A subunit of bacterial DNA gyrase, inhibiting DNA synthesis and replication, leading to bacterial death.

93107-08-5 37
Enalapril Maleate Tablets
Enalapril Maleate
Name Description Content CAS NO. Registered Holders
Enalapril maleate

Angiotensin converting enzyme inhibitor. After oral administration, it is hydrolyzed into Enalaprilat in the body, which strongly inhibits angiotensin converting enzyme, reduces the content of angiotensin II, causes systemic vasodilation, and causes blood pressure reduction. It has a significant antihypertensive effect on dinephrogenic hypertension, mononephrogenic hypertension and spontaneous hypertension rat models.

More

Angiotensin converting enzyme inhibitor. After oral administration, it is hydrolyzed into Enalaprilat in the body, which strongly inhibits angiotensin converting enzyme, reduces the content of angiotensin II, causes systemic vasodilation, and causes blood pressure reduction. It has a significant antihypertensive effect on dinephrogenic hypertension, mononephrogenic hypertension and spontaneous hypertension rat models.

76095-16-4 34
Enalapril Maleate Tablets
Enalapril Maleate
Name Description Content CAS NO. Registered Holders
Enalapril maleate

Angiotensin converting enzyme inhibitor. After oral administration, it is hydrolyzed into Enalaprilat in the body, which strongly inhibits angiotensin converting enzyme, reduces the content of angiotensin II, causes systemic vasodilation, and causes blood pressure reduction. It has a significant antihypertensive effect on dinephrogenic hypertension, mononephrogenic hypertension and spontaneous hypertension rat models.

More

Angiotensin converting enzyme inhibitor. After oral administration, it is hydrolyzed into Enalaprilat in the body, which strongly inhibits angiotensin converting enzyme, reduces the content of angiotensin II, causes systemic vasodilation, and causes blood pressure reduction. It has a significant antihypertensive effect on dinephrogenic hypertension, mononephrogenic hypertension and spontaneous hypertension rat models.

76095-16-4 34
Cefpodoxime Proxetil Tablets
Cefpodoxime Proxetil
Name Description Content CAS NO. Registered Holders
Cefpodoxime proxetil

It has strong antibacterial activity against Staphylococcus, Streptococcus, Pneumococcus, Peptostreptococcus, Gonorrhea, Branhamella catarrhalis, Escherichia coli, Klebsiella, Proteus (Proteus mirabilis, Proteus vulgaris, Providencia rettgeri, Providencia anomala), Citrobacter, Enterobacter, and Haemophilus influenzae.

More

It has strong antibacterial activity against Staphylococcus, Streptococcus, Pneumococcus, Peptostreptococcus, Gonorrhea, Branhamella catarrhalis, Escherichia coli, Klebsiella, Proteus (Proteus mirabilis, Proteus vulgaris, Providencia rettgeri, Providencia anomala), Citrobacter, Enterobacter, and Haemophilus influenzae.

87239-81-4 28
Venlafaxine Hydrochloride Capsules
Venlafaxine hydrochloride. Molecular formula: C17H27NO2HCl Molecular weight: 313.87
Name Description Content CAS NO. Registered Holders
Venlafaxine hydrochloride

This product mainly exerts its antidepressant effect by inhibiting the reuptake of serotonin and norepinephrine by the central nervous system, thereby increasing the concentration of these two monoamine transmitters in the synaptic cleft.

More

This product mainly exerts its antidepressant effect by inhibiting the reuptake of serotonin and norepinephrine by the central nervous system, thereby increasing the concentration of these two monoamine transmitters in the synaptic cleft.

99300-78-4 88
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.